David Steven Friedman MD
Cataract Related, Glaucoma Related
Director Glaucoma Mass Eye and Ear Harvard Medical School
Join to View Full Profile
243 Charles StBoston, MA 02114
Phone+1 617-807-7977
Dr. Friedman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Friedman is an ophthalmologist based in Boston, MA, specializing in cataract and glaucoma-related conditions. He completed his medical degree at Harvard Medical School and pursued further training at Beth Israel Deaconess Medical Center and Sidney Kimmel Medical College/Wills Eye Hospital. He holds an M.P.H. and a Ph.D. in Epidemiology from Johns Hopkins University. Currently, he serves as the Director of Glaucoma at Massachusetts Eye and Ear. Dr. Friedman has published extensively on glaucoma, including advancements in diagnosis and treatment. His accolades include an Achievement Award from the American Academy of Ophthalmology and multiple recognitions for CMS Meaningful Use Certification.
Education & Training
Johns Hopkins UniversityPh.D., Epidemiology, 2007- Johns Hopkins University School of Hygiene and Public HealthM.P.H., 1997
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1993 - 1996
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1992 - 1993
Harvard Medical SchoolClass of 1992
Certifications & Licensure
MA State Medical License 2019 - 2027
MD State Medical License 1996 - 2020
DE State Medical License 2001 - 2005
NJ State Medical License 1994 - 1997
PA State Medical License 1994 - 1996
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Publications & Presentations
PubMed
- Long-term Persistent Angle Closure and Anatomic Changes after Laser Iridotomy in Suspected Primary Angle-Closure.Andrea Servillo, Tin A Tun, Chungkwon Yoo, Rajesh S Kumar, Mani Baskaran
Ophthalmology. 2026-04-01 - 2 citationsGlobal Glaucoma Prevalence: Burden and Projection to 2060.Ziyao Wang, Can Can Xue, Yiman Li, You Wu, Zhe Pan
American Journal of Ophthalmology. 2026-03-01 - ChatGPT-Assisted Glaucoma Diagnosis: A Health-Equitable Multi-Ancestry Analysis Using Visual Field and Optical Coherence Tomography Data.Andy S Huang, Anthony Fam, Hetince Zhao, Nicole Paulescu, Anna Fabczak-Kubicka
American Journal of Ophthalmology. 2026-03-01
Journal Articles
- Ten-year incidence of primary angle closure in elderly Chinese: the Liwan Eye StudyWang L, Huang W, Huang S, Zhang J, Guo X, Friedman DS, Foster PJ, He M, Br J Ophthalmol, 1/18/2018
- Greater Physical Activity Is Associated with Slower Visual Field Loss in GlaucomaLee MJ, Wang J, Friedman DS, Boland MV, De Moraes CG, Ramulu PY, Ophthalmology, 1/10/2018
- Autorefraction-Based Prescription and Mailed Delivery of EyeglassesGajwani P, Varadaraj V, Plum W, Zhao D, Johnson E, Dosto N, Thompson S, Guallar E, Kanwar N, Friedman DS, Mudie LI, Ophthalmology, 1/1/2018
Books/Book Chapters
Abstracts/Posters
- Optimizing approaches to identify glaucoma among at-risk population: the SToP Glaucoma studyFriedman DS, ARVO Annual Meeting, 1/1/2016
- Dark Room Prone Provocative Testing is Uninformative in Primary Angle Closure SubjectsFriedman DS, ARVO Annual Meeting, 1/1/2010
- A Randomized Clinical Trial Evaluating Ready-Made Spectacles in an Adult Population in IndiaFriedman DS, ARVO Annual Meeting, 1/1/2009
Lectures
- Utility of Laser Peripheral Iridoplasty in Patients with Narrow Angles despite Patent Peripheral Iridotomies1/1/2018
- Chloral hydrate sedation has a negligible impact on intraocular pressure (IOP) in infants and young children1/1/2017
- The Unstoppable force of Demographics: How aging will Impact Our Approaches to Glaucoma Treatment1/1/2015
Other
- Treatment of Coexisting Cataract and Glaucoma. Evidence Report/Technology Assessment Number 38. (Prepared by Johns Hopkins University Evidence-based Practice Center un...Jampel H, Lubomski L, Friedman D, AHRQ
Rockville, MD - 1/1/2003 - Vision Problems in the U.S.: Prevention of adult vision impairment and age-related eye disease.Friedman DS, Congdon NG, Kempen J, Tielsch JM, O�Colmain B, Prevent Blindness America
Schaumburg, IL - 1/1/2002 - Anesthesia management during cataract surgery. Evidence Report/Technology Assessment No. 16 (Contract 290-097-0006 to the Johns Hopkins University Evidence-Based Pract...Schein OD, Friedman DS, Fleisher LA, Lubomski LH, Magaziner J, Sprintz M, Kempen J, Reeves SW, Robinson KA, Bass EB, AHRQ
Rockville, MD - 1/1/2000
Press Mentions
Myra Vision Secures FDA Approval to Initiate US-Based IDE Study in GlaucomaAugust 13th, 2025- Research Identifies 29 Retinal Vascular Parameters Linked to StrokeFebruary 6th, 2025
- Scientists Find Gene Mutation Linked to Exfoliation Syndrome, Most Common Cause of GlaucomaMay 4th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
